AL
Agran Libbie Portfolio holdings
AUM
$425M
This Quarter Return
+5.58%
1 Year Return
+16.08%
3 Year Return
+27.54%
5 Year Return
–
10 Year Return
–
AUM
$425M
AUM Growth
+$425M
(+3%)
Cap. Flow
-$6.86M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
30.4%
Holding
133
New
7
Increased
36
Reduced
66
Closed
10
Top Buys
| 1 |
3M
MMM
|
$3.03M |
| 2 |
Douglas Emmett
DEI
|
$1.28M |
| 3 |
Kinder Morgan
KMI
|
$524K |
| 4 |
Alerian MLP ETF
AMLP
|
$384K |
| 5 |
Ventas
VTR
|
$354K |
Top Sells
| 1 |
Martin Midstream Partners
MMLP
|
$3.18M |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
$2.34M |
| 3 |
Donaldson
DCI
|
$1.69M |
| 4 |
ConocoPhillips
COP
|
$889K |
| 5 |
QCP
Quality Care Properties, Inc.
QCP
|
$754K |
Sector Composition
| 1 | Financials | 16.07% |
| 2 | Technology | 16.01% |
| 3 | Energy | 12.6% |
| 4 | Healthcare | 11.25% |
| 5 | Communication Services | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Flowserve
FLS
$7.02B
| $369K | 0.09% |
7,625
-3,570
| -32% | -$173K |
|
102
Philip Morris
PM
$260B
| $369K | 0.09% |
3,266
-22
| -0.7% | -$2.49K |
|
103
Middleby
MIDD
$6.94B
| $368K | 0.09% |
2,700
| – | – |
|
104
EOG Resources
EOG
$68.2B
| $359K | 0.08% |
3,685
+1,050
| +40% | +$102K |
|
105
TC Energy
TRP
$54.1B
| $348K | 0.08% |
7,550
| – | – |
|
106
Altria Group
MO
$113B
| $314K | 0.07% |
4,392
-50
| -1% | -$3.58K |
|
107
Pfizer
PFE
$141B
| $314K | 0.07% |
+9,178
| New | +$314K |
|
108
Schlumberger
SLB
$55B
| $309K | 0.07% |
3,957
+700
| +21% | +$54.7K |
|
109
Johnson Controls International
JCI
$69.9B
| $307K | 0.07% |
7,297
-725
| -9% | -$30.5K |
|
110
Salesforce
CRM
$245B
| $303K | 0.07% |
3,675
-100
| -3% | -$8.25K |
|
111
General Dynamics
GD
$87.3B
| $271K | 0.06% |
1,450
+100
| +7% | +$18.7K |
|
112
Norfolk Southern
NSC
$62.8B
| $253K | 0.06% |
2,260
-75
| -3% | -$8.4K |
|
|
AGN
113
DELISTED
Allergan plc
AGN
| $253K | 0.06% |
+1,060
| New | +$253K |
|
114
Idexx Laboratories
IDXX
$51.8B
| $247K | 0.06% |
+1,600
| New | +$247K |
|
115
Marvell Technology
MRVL
$54.2B
| $238K | 0.06% |
15,600
| – | – |
|
116
Novartis
NVS
$245B
| $223K | 0.05% |
2,996
-75
| -2% | -$5.58K |
|
117
Oneok
OKE
$48.1B
| $213K | 0.05% |
+3,850
| New | +$213K |
|
118
Duke Energy
DUK
$95.3B
| $209K | 0.05% |
2,552
-83
| -3% | -$6.8K |
|
119
Roper Technologies
ROP
$56.6B
| $208K | 0.05% |
+1,005
| New | +$208K |
|
120
Ecolab
ECL
$78.6B
| $201K | 0.05% |
1,600
-207
| -11% | -$26K |
|
121
Catalyst Pharmaceutical
CPRX
$2.52B
| $86K | 0.02% |
44,000
| – | – |
|
122
Arrowhead Research
ARWR
$3.05B
| $38K | 0.01% |
20,600
| – | – |
|
123
Qualigen Therapeutics
QLGN
$3.03M
| $15K | ﹤0.01% |
10,500
| – | – |
|
|
124
Martin Midstream Partners
MMLP
$134M
| – | – |
-17,809
| Closed | -$3.18M |
|
125
Novo Nordisk
NVO
$251B
| – | – |
-6,450
| Closed | -$231K |
|